Biodroga Nutraceuticals Inc

Liminal BioSciences Inc. is a development-stage biopharmaceutical company based in Laval, Québec, dedicated to the treatment of metabolic, fibrotic, and inflammatory diseases. Utilizing a drug discovery platform combined with a data-driven approach, the company focuses on developing distinctive novel small molecule therapeutics. Their expertise in small molecules has established a robust product pipeline with potential first best-in-class drug candidates. Liminal BioSciences Inc. strives to advance innovative therapies that address unmet medical needs in critical areas of health. Generated from the website

BetterLife Pharma Inc. is an emerging biotechnology company based in Dollard-Des Ormeaux, Quebec, dedicated to developing and commercializing patient-friendly therapeutics for neuropsychiatric and neurological disorders. Their innovative approach aims to produce non-hallucinogenic medicines that address a wide range of unmet mental health conditions, including anxiety, depression, and PTSD. The company's lead product, BETR001, is a second-generation LSD derivative designed to mimic the therapeutic properties of LSD without its hallucinogenic side effects. By focusing on evidence-driven solutions, BetterLife Pharma strives to provide effective treatments for debilitating psychiatric disorders and severe neurological conditions, ultimately aiming to enhance the quality of life for patients. Generated from the website